Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. Core study details and navigation remain unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page header now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1. No changes to study content or data are visible.SummaryDifference0.1%

- Check82 days agoChange DetectedShow glossary was added, and metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision/version updated to v3.4.0, replacing the previous v3.3.4 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.